CerFlux
CerFlux, based in Birmingham, AL, is dedicated to revolutionizing cancer treatment through its innovative POET Personalized Oncology Efficacy Test, which allows for tailored therapy selection based on the unique composition of each patient's tumor. By testing multiple treatment agents simultaneously on biopsy tissue, CerFlux identifies the most effective options in less than seven days, minimizing unnecessary suffering and costs for patients.
The company recognizes the complexities of cancer treatment, noting that traditional methods often lead to ineffective overtreatment due to the generalized approach. CerFlux’s commitment to personalized care addresses the urgent need for individualized treatment solutions, matching therapies to patients with greater accuracy and speed.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.